Press Releases

AcuityMD accelerates widespread market access to novel opioid withdrawal treatment device, currently in use across 24 U.S. rehabilitation facilities

Today we’re excited to share that AcuityMD has raised $31M in Series A funding led by Redpoint Venture Partners, with support from Benchmark, the leader of our seed round, as well as Ajax Health and Artisanal Ventures.

AcuityMD enables Dilon to quickly identify the right doctors and medical facilities in urgent need of its life-saving medical technology